A

ABEO

ABEO

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ABEO Live QuoteReal-time
$2.45
$2.06(-45.68%)1M
Day Range$2.42 – $2.76
Open$2.70
Previous Close$2.73
Volume1.91M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$154.10M
P/E Ratio (TTM)24.5
Forward P/E18.7
EPS (TTM)$-1.16
Price to Book1.3
Dividend Yield0.65%
Beta (Volatility)1.48
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $2.45 (6%)
Low: $2.09High: $7.65
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$15.56-89.6% upside

Insider Buys

0

$0

Insider Sales

4

$208K

Total Volume

$208K

4 transactions

Net Activity

$208K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Seshadri Vishwas

CEO

0 buys1 sells

$101K total

V
2

Vazzano Joseph Walter

CFO

0 buys1 sells

$47K total

O
3

O'Malley Brendan M.

SVP, GC

0 buys1 sells

$35K total

V
4

Vasanthavada Madhav

Chief Commercial Officer

0 buys1 sells

$25K total

Trading History
ABEO insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 29, 2026

1 months ago

Seshadri Vishwas

CEO

CEO
Sell19.6K$5.16$101K

Sep 29, 2026

1 months ago

Vazzano Joseph Walter

CFO

CFO
Sell9.2K$5.16$47K

Sep 29, 2026

1 months ago

O'Malley Brendan M.

SVP, GC

SVP
Sell6.7K$5.16$35K

Sep 29, 2026

1 months ago

Vasanthavada Madhav

Chief Commercial Officer

C-Level
Sell4.9K$5.16$25K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ABEO Buy Conviction0%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.52B

ABEO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ABEO

Over the last 90 days, corporate insiders at ABEO (ABEO) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 4 were sales. The total volume of insider trading reached $208K.

The net insider activity for ABEO shows a net selling bias of $208K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Seshadri Vishwas (CEO), who traded 19.6K shares valued at $101K on Sep 29, 2026.

Live Market News & Developments
Aggregated real-time headlines for ABEO (ABEO)
6 updates

Abeona Therapeutics (ABEO) Stock Sees Fair Value Falls As Zevaskyn Ramp Concerns Grow

Yahoo Finance6d ago

Abeona Therapeutics: My 'Buy The Dip' Call Backfired On Q3 Earnings: I'm Downgrading To Hold

Seeking AlphaYesterday

Abeona Therapeutics (NASDAQ:ABEO) Stock: ZEVASKYN Sales and a New Asset Frame the Quarter

kalkine.ca3d ago

Abeona Therapeutics (NasdaqCM:ABEO) Stock Forecast & Analyst Predictions

Simply Wall St8d ago

ABEO - Abeona Therapeutics Inc Stock Price and Quote

Finviz178d ago

$ABEO stock is down 27% today. Here's what we see in our data.

Quiver Quantitative11d ago

FAQs About ABEO Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ABEO.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ABEO is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 4 sales by company executives over the last 90 days.

The CEO Conviction Index for ABEO is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.